Indirect costs of the Rheumatoid arthritis in Poland

It is estimated that about 400,000 people in Poland suffer from rheumatoid arthritis (RA). Only a few epidemiological studies documenting the incidence of musculoskeletal disorders in the Polish population have been conducted. The medical literature mainly states that rheumatoid arthritis affects ap...

Full description

Bibliographic Details
Main Authors: Emilia Howoruszko, Szymon Szumiał, Aleksandra Izabela Czerw
Format: Article
Language:English
Published: Kazimierz Wielki University 2019-05-01
Series:Journal of Education, Health and Sport
Subjects:
Online Access:http://www.ojs.ukw.edu.pl/index.php/johs/article/view/6914
id doaj-7440ad90c4b54cf5975c015cb5177a39
record_format Article
spelling doaj-7440ad90c4b54cf5975c015cb5177a392020-11-25T00:05:31ZengKazimierz Wielki UniversityJournal of Education, Health and Sport2391-83062019-05-019522123110.5281/zenodo.28994376154Indirect costs of the Rheumatoid arthritis in PolandEmilia Howoruszko0Szymon Szumiał1Aleksandra Izabela Czerw2Medical University of Warsaw, Department of Health Economics and Medical LawMedical University of Warsaw, Department of Health Economics and Medical LawMedical University of Warsaw, Department of Health Economics and Medical LawIt is estimated that about 400,000 people in Poland suffer from rheumatoid arthritis (RA). Only a few epidemiological studies documenting the incidence of musculoskeletal disorders in the Polish population have been conducted. The medical literature mainly states that rheumatoid arthritis affects approximately 1% of the population and occurs 2-4 times more often in women than in men. RA is a disease that can develop at any age. In this group of diseases, indirect costs significantly exceed direct costs. Easier and more efficient access to rheumatology outpatient clinics would contribute to a quicker diagnosis of patients and, consequently, to reducing indirect costs of RA, and access to modern therapies would translate into a reduction of indirect costs related to rheumatoid arthritis. Results of studies conducted by other authors available in literature demonstrate that these diseases cause both an increased absence at work, i.e. missing days at work, and presenteeism, i.e. an increased ineffective presence at work due to ill-being. Indirect costs increase with increased disease activity. These costs can be significantly reduced through early diagnosis and introduction of effective treatment.http://www.ojs.ukw.edu.pl/index.php/johs/article/view/6914indirect costsrheumatoid arthritis
collection DOAJ
language English
format Article
sources DOAJ
author Emilia Howoruszko
Szymon Szumiał
Aleksandra Izabela Czerw
spellingShingle Emilia Howoruszko
Szymon Szumiał
Aleksandra Izabela Czerw
Indirect costs of the Rheumatoid arthritis in Poland
Journal of Education, Health and Sport
indirect costs
rheumatoid arthritis
author_facet Emilia Howoruszko
Szymon Szumiał
Aleksandra Izabela Czerw
author_sort Emilia Howoruszko
title Indirect costs of the Rheumatoid arthritis in Poland
title_short Indirect costs of the Rheumatoid arthritis in Poland
title_full Indirect costs of the Rheumatoid arthritis in Poland
title_fullStr Indirect costs of the Rheumatoid arthritis in Poland
title_full_unstemmed Indirect costs of the Rheumatoid arthritis in Poland
title_sort indirect costs of the rheumatoid arthritis in poland
publisher Kazimierz Wielki University
series Journal of Education, Health and Sport
issn 2391-8306
publishDate 2019-05-01
description It is estimated that about 400,000 people in Poland suffer from rheumatoid arthritis (RA). Only a few epidemiological studies documenting the incidence of musculoskeletal disorders in the Polish population have been conducted. The medical literature mainly states that rheumatoid arthritis affects approximately 1% of the population and occurs 2-4 times more often in women than in men. RA is a disease that can develop at any age. In this group of diseases, indirect costs significantly exceed direct costs. Easier and more efficient access to rheumatology outpatient clinics would contribute to a quicker diagnosis of patients and, consequently, to reducing indirect costs of RA, and access to modern therapies would translate into a reduction of indirect costs related to rheumatoid arthritis. Results of studies conducted by other authors available in literature demonstrate that these diseases cause both an increased absence at work, i.e. missing days at work, and presenteeism, i.e. an increased ineffective presence at work due to ill-being. Indirect costs increase with increased disease activity. These costs can be significantly reduced through early diagnosis and introduction of effective treatment.
topic indirect costs
rheumatoid arthritis
url http://www.ojs.ukw.edu.pl/index.php/johs/article/view/6914
work_keys_str_mv AT emiliahoworuszko indirectcostsoftherheumatoidarthritisinpoland
AT szymonszumiał indirectcostsoftherheumatoidarthritisinpoland
AT aleksandraizabelaczerw indirectcostsoftherheumatoidarthritisinpoland
_version_ 1725424929875165184